Page last updated: 2024-08-24

plerixafor and topotecan

plerixafor has been researched along with topotecan in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ackerman, JJH; Beeman, SC; Duan, C; Engelbach, JA; Garbow, JR; Ge, X; Perez-Torres, CJ; Rich, KM; Tsien, CI; Yang, R; Yuan, L1

Reviews

1 review(s) available for plerixafor and topotecan

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for plerixafor and topotecan

ArticleYear
Inhibitors of HIF-1α and CXCR4 Mitigate the Development of Radiation Necrosis in Mouse Brain.
    International journal of radiation oncology, biology, physics, 2018, 03-15, Volume: 100, Issue:4

    Topics: Animals; Benzylamines; Brain; Cyclams; Disease Models, Animal; Disease Progression; Female; Heterocyclic Compounds; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Necrosis; Radiation Injuries, Experimental; Receptors, CXCR4; Topotecan

2018